Author

Maya Muhlbauer Avni

Technion – Israel Institute of TechnologyORCID 0000-0002-6365-4242Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Adi KimchiiD· 1 shared Alon SavidoriD· 1 shared Chen LioriD· 1 shared Hila Belhanes Peled· 1 shared Hila Birisi· 1 shared Judit KrausziD· 1 shared Marcela Bahlsen· 1 shared Nofar David· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adi KimchiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyOncogenePeer-reviewedFeb 22, 2024

Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations with Poorer Survival Outcome in Patients

Sara Meril, Maya Muhlbauer Avni, Chen Lior…·Adi Kimchi

This study shows that low EIF4G2 expression in Grade 2 endometrial cancer correlates with poor survival and drug resistance, suggesting it as a potential biomarker.

8 citations

humanproteomics

𝕏 PostBluesky